Insulet | PODD - Interest Expense On Debt


Insulet reported $11M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Abbott USD 297M 2M Sep/2026
Align Technology USD 6.93M 9.11M Mar/2026
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Boston Scientific USD 96M 6M Jun/2026
Cardinal Health USD 79M 22M Jun/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dexcom USD 3M 100K Jun/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Eli Lilly USD 114.7M 134.3M Sep/2025
Globus Medical USD 5.49B 48.7M Jun/2026
ICU Medical USD 18.53M 2.11M Mar/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.96M 33K Sep/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 186M 10M Jun/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
Solventum Corp USD 14.24B 146M Jun/2026
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
West Pharmaceutical Services USD 2.6M 700K Jun/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026